MENDLEIN JOHN 4
4 · FATE THERAPEUTICS INC · Filed Jun 13, 2022
Insider Transaction Report
Form 4
MENDLEIN JOHN
Director
Transactions
- Award
Common Stock
2022-06-09+8,650→ 166,741 total - Award
Stock Option (Right to Buy)
2022-06-09+11,893→ 11,893 totalExercise: $23.48Exp: 2032-06-09→ Common Stock (11,893 underlying)
Footnotes (2)
- [F1]Award of restricted stock units that vest in full on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
- [F2]The shares subject to this option shall vest and become exercisable on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.